Bone Biologics shares are trading lower after the company priced its public offering of 2.54M shares At $1.97/share.
Portfolio Pulse from Benzinga Newsdesk
Bone Biologics (BBLG) has priced its public offering of 2.54 million shares at $1.97 per share, causing the stock to trade lower.
June 15, 2023 | 10:45 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Bone Biologics' stock is trading lower after pricing its public offering of 2.54 million shares at $1.97 per share.
The stock price of Bone Biologics is likely to go down in the short term due to the pricing of its public offering at $1.97 per share, which is lower than the current market price. This dilutes the value of existing shares and may cause investors to sell their shares, leading to a decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100